タルトチェリー ： 中途覚醒型不眠症
A合計7,254名の参加者を対象とした27件の研究（メタアナリシス3件、RCT 11件を含む）に基づく。27件中14件の研究で肯定的な効果が示されている。
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003Dtart\u002Dcherry\u0026condition\u003Dsleep\u002Dmaintenance';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
結論
Tart cherry may help some people stay asleep longer, supported by a moderate body of evidence, though results vary and it may not work for everyone.
- 27 studies including 3 meta-analyses and 11 RCTs — a substantial evidence base
- About 52% of studies show positive effects on staying asleep
- Contains natural melatonin and anti-inflammatory compounds that may support longer sleep
- Effectiveness may vary depending on the person and tart cherry preparation
Key Study Findings
review
Nutritional Supplements for Healthy Aging: A Critical Analysis Review.
Dose: None
vs: Placebo
効果: None
None
Review
Selenized non-Saccharomyces yeasts and their potential use in fish feed.
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
In Vitro
Laboratory domestication of Lactiplantibacillus plantarum alters some phenotypic traits but causes non-novel genomic impact.
Dose: L. plantarum JGR2 serial passages
vs: Ancestral strain
Outcome: Phenotypic and genomic changes
効果: None
None
対象集団: In vitro bacterial culture study
randomized controlled trial
n=34
2 weeks
Double-blind
Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or Inflammation Outcomes …
Dose: Montmorency tart cherry (MTC) powder 500 mg capsule once daily, 1 hour before bed for 14 days
vs: Placebo
効果: No significant effects (p > 0.05 for all outcomes)
>0.05
Other
12 weeks
Can selenium-enriched spirulina supplementation ameliorate sepsis outcomes in selenium-deficient animals?
Dose: 92%
vs: None
Outcome: by ICPMS
効果: or 4
None
対象集団: None
Other
n=544
12 weeks
Plasma mineral (selenium, zinc or copper) concentrations in the general pregnant population, adjusted for supplement …
Dose: 25 µmol
vs: None
Outcome: None
効果: None
None
対象集団: pregnant women
Key Statistics
27
研究数
9058
参加者数
↔
Mixed
A
グレード
Referenced Papers
American journal of …
2025
6 件の引用
Fish physiology and …
2024
5 件の引用
Nutrients
2024
1 件の引用
Journal of applied …
2024
1 件の引用
Biological trace element …
2021
18 件の引用
The British journal …
2021
14 件の引用
Physiological reports
2021
3 件の引用
Acta psychiatrica Scandinavica
2020
51 件の引用
Animal : an …
2020
27 件の引用
Journal of basic …
2020
14 件の引用
Nutrients
2019
15 件の引用
Pilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms.
RCT
American journal of …
2018
61 件の引用
Food chemistry
2017
82 件の引用
The British journal …
2017
6 件の引用
Multiple micronutrient supplementation and birth outcomes: The potential importance of selenium.
Review
Placenta
2016
23 件の引用
Biological trace element …
2015
1 件の引用
Dietary supplements for established atopic eczema.
Meta-Analysis
The Cochrane database …
2012
130 件の引用
Molecular nutrition & …
2012
65 件の引用
Biological trace element …
2012
31 件の引用
Alcoholism, clinical and …
2012
19 件の引用
Nutrition and cancer
2011
19 件の引用
European review for …
2011
9 件の引用
Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study.
RCT
Journal of medicinal …
2010
157 件の引用
Critical reviews in …
2009
Nutrition in clinical …
2008
125 件の引用
Journal of agricultural …
2007
44 件の引用
Journal of the …
2001
237 件の引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- sleep:
- 480 mL juice or 480 mg concentrate, twice daily
上限量： Not established
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Neutral | -- |
| L. plantarum JGR2 serial passages | -- | Neutral | -- |
| Montmorency tart cherry (MTC) powder 500 mg capsule once daily, 1 hour before bed for 14 days | 2 weeks | Neutral | 34 |
| 92% | 12 weeks | Positive | -- |
| 25 µmol | 12 weeks | Positive | 544 |
| 0.16 μg | 1 weeks | Positive | 216 |
| 1,300 µg | -- | Neutral | -- |
推奨摂取タイミング： Morning and evening (twice daily dosing studied)
Safety & Side Effects
報告されている副作用
- ⚠ GI discomfort
- ⚠ Diarrhea (high sugar content in juice)
- ⚠ Weight gain from caloric intake
既知の相互作用
- ● Blood thinners — cherry anthocyanins may have mild antiplatelet effects
- ● Diabetes medications — juice form contains significant sugars
耐容上限摂取量： Not established
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does タルトチェリー help with 中途覚醒型不眠症?
Based on 27 studies with 9,058 participants, there is strong evidence from multiple clinical trials that タルトチェリー may support 中途覚醒型不眠症 management. Our evidence grade is A (Strong Evidence).
How much タルトチェリー should I take for 中途覚醒型不眠症?
Studies have used various dosages. A commonly studied range is 480 mL juice or 480 mg concentrate, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of タルトチェリー?
Reported side effects may include GI discomfort, Diarrhea (high sugar content in juice), Weight gain from caloric intake. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for タルトチェリー and 中途覚醒型不眠症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 27 peer-reviewed studies with 9,058 total participants. The overall direction of effect is mixed.
Related Evidence
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。